SlideShare a Scribd company logo
1 of 42
MALIGNANT TUMORS OF SKIN
DR MUKHILESH R M.S.,
Salient Features Of Skin Malignancies
 Most commonly epidermal origin

 Basal cell carcinoma
 Squamous cell carcinoma
 Malignant melanoma
 Skin adnexal tumors are rare.
 Chemical carcinogens play a major role.
Basal Cell Carcinoma
 Most common skin tumor, originates from basal layer of epidermis
 Slowly growing , locally invasive – RODENT ULCER.
 26 histological variants.
 Most common are
 Nodular

 Superficial speading
 Infiltrative
 Pigmented & Morpheaform
Predisposing factors
UV rays

Arsenics,
coal , tar

BCC
White
skin,
genetics

Middle
aged,
men
Pathogenesis
 No apparent precursor lesion
 Locally infiltrative.
 Rarely metastasise.
 Never lympatic spread
 Ovoid cells in nests with outer pallisading layer.
Contd…
 Nodulocystic
 Waxy , cream coloured with rolled, pearly borders
surrounding central ulcer.
 Morpheaform
 Type IV collagenase and spread rapidly
 Flat, plaque like lesion
 Basosquamous variant
 Highly aggressive

 Metastasize similar to SCC and aggressive treatment required.
Prognosis
 High risk BCC

 >2cm
 Specific location – nose , ear, eyes
 Ill-defined margins

 Recurrent tumors
 immunosuppression
Management of BCC
 Surgical VS Non Surgical

 Non surgical
 Curettage
 Electrodessication
 Laser vapourisation
 Destroy any potential tissue sample for pathological confirmation and
margin analysis
Surgical Management
 Complete tumor removal , with pathological confirmation and margin analysis.

 Large tumors invading adjacent structure with aggressive histology – WIDE LOCAL EXCISION
 0.5-1cm margin
 Reconstructive procedures
MOHS Micrographic Surgery
 Excision of skin cancer under microscopic control.

 Minimise recurrent rates with maximum conservation.
 Indicated in
 Poorly demarcated,
 Recurrent / incompletely excised
 Near vital structures

 Can also be used for SCC, lentigo maligna,DFS
Contd…

Under local
anesthesia
Saucerising excision
of primary tumor

Sample and defect
are marked and
oriented
Stained with H&E.

Examination of
slide for residual
tumor

Excise more tissue
from mapped area.
Contd…
Other Modalaties
 Radiotherapy

 Topical treatments
 5-fluorouracil
 Imiquimod
 Cryotherapy
Cutaneous Squamous Cell Carcinoma
 Malignant tumor of keratinising epithelium of epidermis

 2nd most common tumor
 Cumulative sun exposure and damage
 Associated with pre-existing scars, osetomyelitis, burn.
 Marjolin’s ulcer
Pathogenesis
Sun exposure

Scars and
sinuses

Chemical
carcinogens

SCC

Tobacco use

HPV 5 & HPV
16
Pathology
 Smooth nodular to verrucous , papillamatous and ulcerating lesions.

 Everted edges and surrounded by inflamed, indurated skin.
 Distant metastasis.
 Secondary lymph nodes involvement.
Differential Diagnosis Of SCC
 Actinic keratosis

 BCC
 Keratoacanthoma
 Pyoderma gangrenosum
 Warts
Microscopic Appearance
 Irregular masses of squamous epithelium proliferate and invade dermis.

 KERATIN PEARLS
 Perineural / vascular invasion
 Positive for cytokeratin 1 and 10
 Border’s histological grading
 Ratio of pleomorphic and anaplastic to normal cells
Prognosis
 Invasion
 Depth – deeper lesion , worse the prognosis
 Surface size - >2 cm
 Histological grade
 Site
 Lips and ears – increase recurrent rate
 Immunosuppression
 Perineural and vascular involvement

 Aetiology
TNM Classification
Size
• T1 - <2cm
• T2 - 2-5 cm
• T3 - >5cm
• T4 - muscle or
bone
involvement

Nodes
• N0 - no
regional
nodes
• N1 - regional
nodes

Metastasis
• M0 - no
metastasis
• M1- distant
metastasis

Grade
• G1- low grade
• G2moderately
differentiated
• G3- high
grade
Management
 Surgical excision – accurate histology

 Margins to be assessed
 4mm clearance for <2cm
 1 cm clearance for >2cm
 Radiotherapy resistant – Veruccus carcinoma
Malignant Melanoma
 Cancer of melanocytes

 Wherever melanocytes exist
 Bowel mucosa
 Retina
 Leptomeninges
Macroscopic Features In Nevi
Suggesting Malignant Melanoma
Contd…
 Tingling

 Itching
 Serosanguinous discharge
 Blood supply
 Melanomas >1mm have blood supply – doppler positive pigmented
lesion
Types Of Malignant Melanoma
 Superficial spreading

 Nodular melanoma
 Lentigo maligna melanoma
 Acral lentiginous melanoma
 Amelanotic melanoma
 Desmoplastic melanoma
Superficial Spreading Melanoma
 Commonest type – 70%

 Arise from pre – existing nevus
 Rapid growth of darker pigmented are in a junctional nevus.
 Predominantly radial growth phase.
 Nodularity can occur – vertical growth phase.
Nodular Melanoma
 More aggressive

 Increased vertical growth than radial phase
 Middle age men.
 Usually trunk.
 Sharply demarcated, blue-black papules 1-2cm.
 Lack horizontal growth phase.
Lentigo Maligna Melanoma
 Hutchinson’s melanotic freckle

 Slow growing, variegated, brown macule
 Intense sun exposure.
 Women > men
 Less metastaic potential
 Better prognosis
Acral Lentiginous Melanoma
 Soles of feet and palms of hand
 Rare in white skinned people
 Flat, irregular macule.
 Can mimic a fungal infection
 Biopsy of the nail matrix rather than just the pigment.

 Hutchinson’s sign nail-fold pigmentation then widens progressively to
produce a triangular pigmented macule with nail dystrophy.
Miscellaneous
 Amelanotic melanoma
 Not pigmented
 Poor prognosis

 Desmoplastic melanoma
 Head and neck
 Perineural invasion

 High recurrent rate
Histology
 Malignant changes of melanocytes in basal epidermis
 Horizontal growth phase – cells spread along the dermo-epidermal
junction
 Vertical growth phase – dermis may be invaded and increased metastatic
potential.
 Satellite nodules
 Lesions situated with in 2-5cm of the primary
 Intransit lesions
 Situated >5cm , proximal to lymphnode basin
Management
 History and clinical examination

 Excision biopsy with 2mm margin of skin and subdermal fat.
 Incisional biopsy – large lesion / facial lesions where excision results in
scarring.
 Staging of melanoma
 Clarkes’ staging

 Breslows’ classification
Staging Of Melanoma
Management Of Malignant Melanoma
Pigmented
lesion
Biopsy

Diagnosis of melanoma
<1mm depth
Excision - 1cm
margin

2-4mm
depth
Excision -2cm
margin

>4mm depth
Excision – 3cm
margin
Management of lymphnodes
 Based on breslow thickness.

 <1mm least beneficial with prophylactic dissection.
 >4mm increased chance of both lymphatic and distant metastasis.
 Intermediate thickness
 Elective prophylactic lymph node dissection
 Sentinel lymphnode biopsy
Sentinel Lymphnode Biopsy
Sentinel Lymphnode Biopsy
Other Modalities
 Chemotherapy

 Melphalan
 Vemurafenib
 Isolated limb perfusion therapy

 Immunotherapy
 IFN / TNF ALPHA
 Radiotherapy
Malignant tumors of skin

More Related Content

What's hot

Basal cell carcnoma
Basal cell carcnomaBasal cell carcnoma
Basal cell carcnoma
Firas Kassab
 

What's hot (20)

Soft tissue tumor
Soft tissue tumorSoft tissue tumor
Soft tissue tumor
 
Benign skin lesions
Benign skin lesionsBenign skin lesions
Benign skin lesions
 
Skin tumors
Skin tumorsSkin tumors
Skin tumors
 
Skin Cancer
Skin CancerSkin Cancer
Skin Cancer
 
Basal cell carcnoma
Basal cell carcnomaBasal cell carcnoma
Basal cell carcnoma
 
Skin Cancer
Skin CancerSkin Cancer
Skin Cancer
 
Skin Malignancies BCC SCC MM
Skin Malignancies BCC SCC MMSkin Malignancies BCC SCC MM
Skin Malignancies BCC SCC MM
 
Pathology of Skin - Common Disorders
Pathology of Skin - Common DisordersPathology of Skin - Common Disorders
Pathology of Skin - Common Disorders
 
Palmoplantar Keratodermas
Palmoplantar KeratodermasPalmoplantar Keratodermas
Palmoplantar Keratodermas
 
Squamous Cell Carcinoma
Squamous Cell CarcinomaSquamous Cell Carcinoma
Squamous Cell Carcinoma
 
Basal cell carcinoma presented by Dr.Varughese.
Basal cell carcinoma presented by Dr.Varughese.Basal cell carcinoma presented by Dr.Varughese.
Basal cell carcinoma presented by Dr.Varughese.
 
SCC
SCCSCC
SCC
 
Premalignant lesions of skin
Premalignant lesions of skinPremalignant lesions of skin
Premalignant lesions of skin
 
Primary cutaneous lymphoma
Primary cutaneous lymphoma  Primary cutaneous lymphoma
Primary cutaneous lymphoma
 
Skin tumors
Skin tumorsSkin tumors
Skin tumors
 
Squamous Cell Carcinoma (SCC)
Squamous Cell Carcinoma (SCC)Squamous Cell Carcinoma (SCC)
Squamous Cell Carcinoma (SCC)
 
Soft tissue tumours
Soft tissue tumours Soft tissue tumours
Soft tissue tumours
 
Melanoma
MelanomaMelanoma
Melanoma
 
Melanocytic lesions. Pathology
Melanocytic lesions. Pathology Melanocytic lesions. Pathology
Melanocytic lesions. Pathology
 
Paget disease of the breast
Paget disease of the breastPaget disease of the breast
Paget disease of the breast
 

Similar to Malignant tumors of skin

Skin cancer Лекция - 2 дополненная перевод — копия 2.pptx
Skin cancer  Лекция - 2  дополненная перевод — копия 2.pptxSkin cancer  Лекция - 2  дополненная перевод — копия 2.pptx
Skin cancer Лекция - 2 дополненная перевод — копия 2.pptx
Singh99882
 
Malignant Melanoma
Malignant MelanomaMalignant Melanoma
Malignant Melanoma
Sariu Ali
 
Soft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptxSoft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptx
hussainAltaher
 

Similar to Malignant tumors of skin (20)

MELANOMA (Dr BASTIAN)
MELANOMA (Dr BASTIAN)MELANOMA (Dr BASTIAN)
MELANOMA (Dr BASTIAN)
 
Malignant skin tumors
Malignant skin tumorsMalignant skin tumors
Malignant skin tumors
 
Skin & soft tissue lesions
Skin & soft tissue lesions   Skin & soft tissue lesions
Skin & soft tissue lesions
 
Malignant melanoma A-Z
Malignant melanoma A-ZMalignant melanoma A-Z
Malignant melanoma A-Z
 
Salivary gland tumor
Salivary gland tumorSalivary gland tumor
Salivary gland tumor
 
Skin cancer Лекция - 2 дополненная перевод — копия 2.pptx
Skin cancer  Лекция - 2  дополненная перевод — копия 2.pptxSkin cancer  Лекция - 2  дополненная перевод — копия 2.pptx
Skin cancer Лекция - 2 дополненная перевод — копия 2.pptx
 
tumoroforalcavity-.pptx
tumoroforalcavity-.pptxtumoroforalcavity-.pptx
tumoroforalcavity-.pptx
 
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .pptmalignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
 
Anterior eye structures disorders
Anterior eye structures disordersAnterior eye structures disorders
Anterior eye structures disorders
 
Malignant Melanoma
Malignant MelanomaMalignant Melanoma
Malignant Melanoma
 
Histopathology of malignant melanoma
Histopathology of malignant melanomaHistopathology of malignant melanoma
Histopathology of malignant melanoma
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)
 
TUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptxTUMOURS OF EYELID AND ORBIT.pptx
TUMOURS OF EYELID AND ORBIT.pptx
 
Tumor of oral cavity
Tumor of oral cavityTumor of oral cavity
Tumor of oral cavity
 
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinomaSquamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
Squamous cell carcinoma, Basal cell carcinoma, Sebaceous gland carcinoma
 
Skin,.pptx
Skin,.pptxSkin,.pptx
Skin,.pptx
 
Malignant melanoma of the oral cavity
Malignant melanoma of the oral cavityMalignant melanoma of the oral cavity
Malignant melanoma of the oral cavity
 
Cutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptxCutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptx
 
Soft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptxSoft tissues tumors. general surgerypptx
Soft tissues tumors. general surgerypptx
 
MALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdfMALIGNANT MELANOMA.pdf
MALIGNANT MELANOMA.pdf
 

More from Mukhilesh Ramesh (6)

varicose veins
varicose veinsvaricose veins
varicose veins
 
Benign diseases of breast
Benign diseases of breastBenign diseases of breast
Benign diseases of breast
 
Head injury
Head injuryHead injury
Head injury
 
Thyrotoxicosis
ThyrotoxicosisThyrotoxicosis
Thyrotoxicosis
 
Chest trauma
Chest traumaChest trauma
Chest trauma
 
early breast cancer management
early breast cancer managementearly breast cancer management
early breast cancer management
 

Recently uploaded

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 

Malignant tumors of skin

  • 1. MALIGNANT TUMORS OF SKIN DR MUKHILESH R M.S.,
  • 2. Salient Features Of Skin Malignancies  Most commonly epidermal origin  Basal cell carcinoma  Squamous cell carcinoma  Malignant melanoma  Skin adnexal tumors are rare.  Chemical carcinogens play a major role.
  • 3. Basal Cell Carcinoma  Most common skin tumor, originates from basal layer of epidermis  Slowly growing , locally invasive – RODENT ULCER.  26 histological variants.  Most common are  Nodular  Superficial speading  Infiltrative  Pigmented & Morpheaform
  • 4. Predisposing factors UV rays Arsenics, coal , tar BCC White skin, genetics Middle aged, men
  • 5. Pathogenesis  No apparent precursor lesion  Locally infiltrative.  Rarely metastasise.  Never lympatic spread  Ovoid cells in nests with outer pallisading layer.
  • 6. Contd…  Nodulocystic  Waxy , cream coloured with rolled, pearly borders surrounding central ulcer.  Morpheaform  Type IV collagenase and spread rapidly  Flat, plaque like lesion  Basosquamous variant  Highly aggressive  Metastasize similar to SCC and aggressive treatment required.
  • 7. Prognosis  High risk BCC  >2cm  Specific location – nose , ear, eyes  Ill-defined margins  Recurrent tumors  immunosuppression
  • 8. Management of BCC  Surgical VS Non Surgical  Non surgical  Curettage  Electrodessication  Laser vapourisation  Destroy any potential tissue sample for pathological confirmation and margin analysis
  • 9. Surgical Management  Complete tumor removal , with pathological confirmation and margin analysis.  Large tumors invading adjacent structure with aggressive histology – WIDE LOCAL EXCISION  0.5-1cm margin  Reconstructive procedures
  • 10. MOHS Micrographic Surgery  Excision of skin cancer under microscopic control.  Minimise recurrent rates with maximum conservation.  Indicated in  Poorly demarcated,  Recurrent / incompletely excised  Near vital structures  Can also be used for SCC, lentigo maligna,DFS
  • 11. Contd… Under local anesthesia Saucerising excision of primary tumor Sample and defect are marked and oriented Stained with H&E. Examination of slide for residual tumor Excise more tissue from mapped area.
  • 13. Other Modalaties  Radiotherapy  Topical treatments  5-fluorouracil  Imiquimod  Cryotherapy
  • 14. Cutaneous Squamous Cell Carcinoma  Malignant tumor of keratinising epithelium of epidermis  2nd most common tumor  Cumulative sun exposure and damage  Associated with pre-existing scars, osetomyelitis, burn.  Marjolin’s ulcer
  • 16. Pathology  Smooth nodular to verrucous , papillamatous and ulcerating lesions.  Everted edges and surrounded by inflamed, indurated skin.  Distant metastasis.  Secondary lymph nodes involvement.
  • 17. Differential Diagnosis Of SCC  Actinic keratosis  BCC  Keratoacanthoma  Pyoderma gangrenosum  Warts
  • 18. Microscopic Appearance  Irregular masses of squamous epithelium proliferate and invade dermis.  KERATIN PEARLS  Perineural / vascular invasion  Positive for cytokeratin 1 and 10  Border’s histological grading  Ratio of pleomorphic and anaplastic to normal cells
  • 19. Prognosis  Invasion  Depth – deeper lesion , worse the prognosis  Surface size - >2 cm  Histological grade  Site  Lips and ears – increase recurrent rate  Immunosuppression  Perineural and vascular involvement  Aetiology
  • 20. TNM Classification Size • T1 - <2cm • T2 - 2-5 cm • T3 - >5cm • T4 - muscle or bone involvement Nodes • N0 - no regional nodes • N1 - regional nodes Metastasis • M0 - no metastasis • M1- distant metastasis Grade • G1- low grade • G2moderately differentiated • G3- high grade
  • 21. Management  Surgical excision – accurate histology  Margins to be assessed  4mm clearance for <2cm  1 cm clearance for >2cm  Radiotherapy resistant – Veruccus carcinoma
  • 22. Malignant Melanoma  Cancer of melanocytes  Wherever melanocytes exist  Bowel mucosa  Retina  Leptomeninges
  • 23.
  • 24. Macroscopic Features In Nevi Suggesting Malignant Melanoma
  • 25. Contd…  Tingling  Itching  Serosanguinous discharge  Blood supply  Melanomas >1mm have blood supply – doppler positive pigmented lesion
  • 26. Types Of Malignant Melanoma  Superficial spreading  Nodular melanoma  Lentigo maligna melanoma  Acral lentiginous melanoma  Amelanotic melanoma  Desmoplastic melanoma
  • 27. Superficial Spreading Melanoma  Commonest type – 70%  Arise from pre – existing nevus  Rapid growth of darker pigmented are in a junctional nevus.  Predominantly radial growth phase.  Nodularity can occur – vertical growth phase.
  • 28. Nodular Melanoma  More aggressive  Increased vertical growth than radial phase  Middle age men.  Usually trunk.  Sharply demarcated, blue-black papules 1-2cm.  Lack horizontal growth phase.
  • 29. Lentigo Maligna Melanoma  Hutchinson’s melanotic freckle  Slow growing, variegated, brown macule  Intense sun exposure.  Women > men  Less metastaic potential  Better prognosis
  • 30. Acral Lentiginous Melanoma  Soles of feet and palms of hand  Rare in white skinned people  Flat, irregular macule.  Can mimic a fungal infection  Biopsy of the nail matrix rather than just the pigment.  Hutchinson’s sign nail-fold pigmentation then widens progressively to produce a triangular pigmented macule with nail dystrophy.
  • 31. Miscellaneous  Amelanotic melanoma  Not pigmented  Poor prognosis  Desmoplastic melanoma  Head and neck  Perineural invasion  High recurrent rate
  • 32. Histology  Malignant changes of melanocytes in basal epidermis  Horizontal growth phase – cells spread along the dermo-epidermal junction  Vertical growth phase – dermis may be invaded and increased metastatic potential.
  • 33.  Satellite nodules  Lesions situated with in 2-5cm of the primary  Intransit lesions  Situated >5cm , proximal to lymphnode basin
  • 34. Management  History and clinical examination  Excision biopsy with 2mm margin of skin and subdermal fat.  Incisional biopsy – large lesion / facial lesions where excision results in scarring.  Staging of melanoma  Clarkes’ staging  Breslows’ classification
  • 36.
  • 37. Management Of Malignant Melanoma Pigmented lesion Biopsy Diagnosis of melanoma <1mm depth Excision - 1cm margin 2-4mm depth Excision -2cm margin >4mm depth Excision – 3cm margin
  • 38. Management of lymphnodes  Based on breslow thickness.  <1mm least beneficial with prophylactic dissection.  >4mm increased chance of both lymphatic and distant metastasis.  Intermediate thickness  Elective prophylactic lymph node dissection  Sentinel lymphnode biopsy
  • 41. Other Modalities  Chemotherapy  Melphalan  Vemurafenib  Isolated limb perfusion therapy  Immunotherapy  IFN / TNF ALPHA  Radiotherapy